This is a routine executive departure with no financial guidance or operational changes. Monitor for any future 8-K regarding a replacement for the Executive Chair role, but no immediate trading action is warranted.
Price Chart
Executive Summary
Tango Therapeutics disclosed the end of Dr. Barbara Weber's employment as Executive Chair, effective August 3, 2026, with her resignation from all officer and board positions. The departure is not due to any disagreement with the company, and a separation agreement with standard severance benefits has been offered. This is a routine executive transition with no financial impact disclosed, making it a neutral event for the stock.
Key Facts
- Dr. Barbara Weber's employment as Executive Chair ended on August 3, 2026.
- Dr. Weber resigned from all officer and board member positions, including the board of directors.
- The resignation was not a result of any disagreement with the company.
- The company offered severance pay through December 31, 2026, COBRA reimbursement, and accelerated vesting of certain equity awards.
- CEO Malte Peters remains in place; no other executive changes were announced.
Financial Impact
Severance pay at current base salary through Dec 31, 2026, plus COBRA reimbursement and accelerated vesting of 12 months of equity awards — amounts not disclosed.
Risk Factors
- Potential leadership vacuum if a new Executive Chair is not named promptly.
- Minor overhang from accelerated equity vesting, though amounts are undisclosed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-338480 |
| Document: 0001193125-26-338480-index-headers.html | 0001193125-26-338480 |
| Document: 0001193125-26-338480-index.html | 0001193125-26-338480 |
| Document: 0001193125-26-338480.txt | 0001193125-26-338480 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | 8-K | $25.58 $25.20 | ▲ +1.49% | ▲ +1.04% | $23.20 (+9.28%) |
Aug 11, 2026 7w ago | 8-K | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 11, 2026 7w ago | Press Release | $26.34 $25.44 | ▼ −3.42% | ▼ −3.01% | $23.20 (−11.90%) |
Aug 9, 2026 7w ago | Institutional Cluster | $27.67 $25.29 | ▼ −8.60% | ▼ −8.55% | $23.20 (−16.14%) |
Aug 6, 2026 8w ago | 8-K | $27.07 $25.60 | ▼ −5.43% | ▼ −5.83% | $23.20 (−14.28%) |
Jun 11, 2026 16w ago | 144 | $30.94 $27.97 | ▼ −9.60% | ▼ −10.27% | $23.20 (−25.00%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 11, 2026 16w ago | Institutional Cluster | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 424B5 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
Jun 10, 2026 16w ago | 144 | $29.82 $32.29 | ▲ +8.28% | ▲ +7.85% | $23.20 (−22.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access